Rannazzisi J T
Office of Diversion Control, Drug Enforcement Administration, Alexandria, Virginia, USA.
Clin Pharmacol Ther. 2007 Jun;81(6):805-6. doi: 10.1038/sj.clpt.6100212.
In their article in this issue, Reidenberg and Willis assert that there are multiple barriers to the adequate treatment of pain and that one of these barriers is fear of government action against a physician who prescribes opioids for patients in pain.(1) At the same time, the authors state that the risk of a physician's being punished by either a state medical board or the Drug Enforcement Administration (DEA) for a patient in pain with adequate medical record documentation is very small.
在本期他们的文章中,赖登伯格和威利斯断言,充分治疗疼痛存在多重障碍,其中一个障碍是担心政府会对为疼痛患者开具阿片类药物的医生采取行动。(1)与此同时,作者指出,对于有充分病历记录的疼痛患者,医生受到州医学委员会或药品管理局(DEA)处罚的风险非常小。